Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Osteoporosis × Anastrozole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 11 Triple Negative Breast Neoplasms 1 Osteoporosis 1 Neoplasm Metastasis 1 Joint Diseases 1 Breast Carcinoma In Situ 1 Bone Diseases, Metabolic 1

Interventions

Risedronic Acid 2 Progesterone 1 Kyphoplasty 1 Hormone Replacement Therapy 1 Estradiol 1 Diphosphonates 1 Denosumab 1 Aromatase Inhibitors 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00082277 2011-01-26

SABRE

AstraZeneca

Phase 4 Completed

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡